![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Aftimos, Philippe; Oliveira, Mafalda; Irrthum, Alexandre; Fumagalli, Debora; Sotiriou, Christos; Gal-Yam, Einav Nili; Robson, Mark E.; Ndozeng, Justin; Di Leo, Angelo; Ciruelos, Eva M.; de Azambuja, Evandro; Viale, Giuseppe; Scheepers, Elsemieke D.; Curigliano, Giuseppe; Bliss, Judith M.; Reis-Filho, Jorge S.; Colleoni, Marco; Balic, Marija; Cardoso, Fatima; Albanell, Joan; Duhem, Caroline; Marreaud, Sandrine; Romagnoli, Dario; Rojas, Beatriz; Gombos, Andrea; Wildiers, Hans; Guerrero-Zotano, Angel; Hall, Peter; Bonetti, Andrea; Larsson, Karolina Fs; Degiorgis, Martina; Khodaverdi, Silvia; Greil, Richard; Sverrisdottir, Asgerdur; Paoli, Marta; Seyll, Ethel; Loibl, Sibylle; Linderholm, Barbro; Zoppoli, Gabriele; Davidson, Nancy E.; Johannsson, Oskar Th; Bedard, Philippe L.; Loi, Sherene; Knox, Susan; Cameron, David A.; Harbeck, Nadia; Montoya, Maite Lasa; Brandao, Mariana; Vingiani, Andrea; Caballero, Carmela; Hilbers, Florentine S.; Yates, Lucy R.; Benelli, Matteo; Venet, David und Piccart, Martine J.
(2021):
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
In: Cancer Discovery, Bd. 11, Nr. 11: S. 2796-2811
Schoffski, Patrick; Sufliarsky, Jozef; Gelderblom, Hans; Blay, Jean-Yves; Strauss, Sandra J.; Stacchiotti, Silvia; Rutkowski, Piotr; Lindner, Lars H.; Leahy, Michael G.; Italiano, Antoine; Isambert, Nicolas; Debiec-Rychter, Maria; Sciot, Raf; Cann, Thomas van; Marreaud, Sandrine; Nzokirantevye, Axelle; Collette, Sandra und Wozniak, Agnieszka
(2018):
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.
In: Lancet Respiratory Medicine, Bd. 6, Nr. 6: S. 431-441
Lindner, Lars H.; Litiere, Saskia; Sleijfer, Stefan; Benson, Charlotte; Italiano, Antoine; Kasper, Bernd; Messiou, Christina; Gelderblom, Hans; Wardelmann, Eva; Le Cesne, Axel; Blay, Jean-Yves; Marreaud, Sandrine; Hindi, Nadia; Desar, Ingrid M. E.; Gronchi, Alessandro und Graaf, Winette T. van der
(2018):
Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
In: International Journal of Cancer, Bd. 142, Nr. 12: S. 2610-2620
Schoffski, Patrick; Wozniak, Agnieszka; Escudier, Bernard; Rutkowski, Piotr; Anthoney, Alan; Bauer, Sebastian; Sufliarsky, Jozef; Herpen, Carla van; Lindner, Lars H.; Grünwald, Viktor; Zakotnik, Branko; Lerut, Evelyne; Debiec-Rychter, Maria; Marreaud, Sandrine; Lia, Michela; Raveloarivahy, Tiana; Collette, Sandra und Albiges, Laurence
(2017):
Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial.
In: European Journal of Cancer, Bd. 87: S. 147-163
Casali, Paolo G.; Zalcberg, John; Cesne, Axel le; Reichardt, Peter; Blay, Jean-Yves; Lindner, Lars H.; Judson, Ian R.; Schoffski, Patrick; Leyvraz, Serge; Italiano, Antoine; Grunwald, Viktor; Pousa, Antonio Lopez; Kotasek, Dusan; Sleijfer, Stefan; Kerst, Jan M.; Rutkowski, Piotr; Fumagalli, Elena; Hogendoorn, Pancras; Litiere, Saskia; Marreaud, Sandrine; Graaf, Winette van der; Gronchi, Alessandro und Verweij, Jaap
(2017):
Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels.
In: Journal of Clinical Oncology, Bd. 35, Nr. 15: S. 1713-1720